Physician profile
James Boynton
NPI 1700951365
$3,097.15
in general payments reported to CMS, 2019-2025
11 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $352 · 2021: $322 · 2022: $671 · 2023: $307 · 2024: $374 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $842.73 | 2019-2022 | |
| Mentor Worldwide LLC | $643.49 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $388.99 | 2019-2021 | |
| Allergan, INC. | $310.29 | 2019-2022 | |
| Davol INC. | $252.23 | 2022-2024 | Arista Ah Flexitip, Phasix Mesh |
| Innovation Technologies INC | $204.65 | 2023-2025 | Irrisept |
| Galderma Laboratories, L.P. | $174.78 | 2019-2022 | |
| Tela Bio, INC. | $166.55 | 2024 | Ovitex 2s |
| Bard Peripheral Vascular, INC. | $78.99 | 2021 | |
| Kci USA, INC. | $17.65 | 2021 | |
| Ucb, INC. | $16.80 | 2025 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Boynton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.